Finasteride is effective for the treatment of central serous chorioretinopathy – (Eye 30, 850 (June 2016))
Finasteride is effective for the treatment of central serous chorioretinopathy Eye 30, 850 (June 2016). doi:10.1038/eye.2016.53 Authors: E Moisseiev, A J Holmes, A Moshiri & L S Morse
The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjögren’s syndrome: a pilot study – (Eye 30, 857 (June 2016))
The increase of aqueous tear volume by diquafosol sodium in dry-eye patients with Sjögren’s syndrome: a pilot study Eye 30, 857 (June 2016). doi:10.1038/eye.2016.54 Authors: N Yokoi, H Kato & S Kinoshita
Development and validation of a Bayesian network for the differential diagnosis of anterior uveitis – (Eye 30, 865 (June 2016))
Development and validation of a Bayesian network for the differential diagnosis of anterior uveitis Eye 30, 865 (June 2016). doi:10.1038/eye.2016.64 Authors: J J González-López, Á M García-Aparicio, D Sánchez-Ponce, N Muñoz-Sanz, N Fernandez-Ledo, P Beneyto & M C Westcott
Does delay in referral of proliferative diabetic retinopathy from the diabetic eye screening programme lead to visual loss? – (Eye 30, 873 (June 2016))
Does delay in referral of proliferative diabetic retinopathy from the diabetic eye screening programme lead to visual loss? Eye 30, 873 (June 2016). doi:10.1038/eye.2016.56 Authors: G S Negretti, R Amin, L Webster & C A Egan
Silencing of S100A4, a metastasis-associated protein, inhibits retinal neovascularization via the downregulation of BDNF in oxygen-induced ischaemic retinopathy – (Eye 30, 877 (June 2016))
Silencing of S100A4, a metastasis-associated protein, inhibits retinal neovascularization via the downregulation of BDNF in oxygen-induced ischaemic retinopathy Eye 30, 877 (June 2016). doi:10.1038/eye.2016.43 Authors: G Cheng, T He & Y Xing